Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

DYNDYN
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in DYNE THERAPEUTICS INC

JPMORGAN CHASE & CO holds 3.2M shares of DYN (DYNE THERAPEUTICS INC), worth $67.2M as of 2026-Q2. The position was decreased (-3.1% shares). DYN represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$67.2M

Current Shares

3.2M

Total Value Change

+$64.8M

Total Shares Change

+3.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.2M
-3.1%
$67.2M0.0%$22.21
0
2026-Q1
Decreased
3.3M
-8.3%
$55.6M0.0%$14.60
0
2025-Q4
Decreased
3.5M
-47.3%
$69.4M0.0%$19.20
0
2025-Q3
Increased
6.7M
+118.0%
$85.1M0.0%$12.37
48
2025-Q2
Increased
3.1M
+21.9%
$29.4M0.0%$9.57
35
2025-Q1
Increased
2.5M
+2472.8%
$26.5M0.0%$11.45
46
2024-Q4
New
98,387
-
$2.3M0.0%$23.65
36

Other major holders of DYN: BlackRock, Inc., Janus Henderson Group Ltd., BlackRock Finance, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used